Navigation Links
Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests
Date:12/11/2008

REHOVOT, Israel, JERSEY CITY, New Jersey and PHILADELPHIA, December 11 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced today the commercial availability of its first diagnostic test, miRview(TM) squamous. The test is now commercially available through Rosetta Genomics CLIA-certified lab in Philadelphia.

To order the test, physicians may contact 1-888-522-7971, or visit the company's website http://www.rosettagenomics.com.

"The introduction of miRview(TM) squamous, our first microRNA-based test, is a landmark event for us at Rosetta Genomics," said Amir Avniel, President and CEO of Rosetta Genomics. "We are excited to be offering the first objective diagnostic test for differentiation of NSCLC patients, which is based on our proprietary microRNA technology. miRview(TM) squamous offers physicians a standardized, quantitative diagnostic tool which may assist in determining the appropriate targeted therapy for NSCLC."

The test has a reported sensitivity of 97%, and a specificity of 91% in identifying squamous cell lung cancer. Classification accuracy was measured in a blinded test of a validation set of 64 samples, compared to the consensus diagnosis of at least two pathologists.

In blinded tests of lab-to-lab concordance, two labs reached the same classification in >95% of classified samples.

"We have traveled a significant distance from first discovering microRNA sequences, through the development of our proprietary detection and quantification technologies, to having our first commercially available microRNA-based test," noted Dr. Dalia Cohen, Rosetta Genomics Chief Scientific Office." miRview(TM) squamous is designed to offer a quantitative, objective, and standardized diagnostic tool for differentiating squamous from non
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
2. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
3. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
5. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
6. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
7. First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval
8. M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
9. Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum
10. MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma
11. Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics miRview(TM) Squamous Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Research and Markets ( http://www.researchandmarkets.com/research/942kh3/micro_market ... "Micro Market Monitor: North American Dermatology Diagnostic Devices ... http://photos.prnewswire.com/prnh/20130307/600769 Cosmetic ... has resulted in fueling the overall demand of ... of these dermatology devices is to assist in ...
(Date:12/19/2014)... Dec. 18, 2014  RESMED INC. (NYSE: RMD ... of fiscal year 2015 results on Thursday, January 22, 2015, ... release with ResMed,s results will be issued after 1:00 p.m. ... to discuss operating results and future outlook. The ... Pacific Time and the live webcast of the call can ...
(Date:12/19/2014)... , Dec. 19, 2014  Eli Lilly and ... Paris: FR0011184241 – ADOC) today announced a worldwide licensing ... BioChaperone Lispro, for treatment in people with type 1 ... proprietary BioChaperone® technology and is currently in Phase Ib ... Lispro with the goal of optimizing glucose levels during ...
Breaking Medicine Technology:Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3ResMed To Announce Second Quarter 2015 Results 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3
... NetMotion Wireless, a leading provider of mobile productivity ... mobile Virtual Private Network (VPN) solution, Mobility XE, has ... hundreds of mobile workers for accessing wireless data and ... advance medical care, improve staff productivity and increase practice ...
... Sept. 7 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) ... conferences in September: Morgan Stanley Global Healthcare Conference ... York Stifel Nicolaus 2010 Healthcare ConferenceWednesday, September 15, at ... Conference Tuesday, September 21, at 9:00 a.m. ET in ...
Cached Medicine Technology:NetMotion Wireless Tapped by IDEXX Laboratories to Provide Secure Mobile Access to Field Personnel 2NetMotion Wireless Tapped by IDEXX Laboratories to Provide Secure Mobile Access to Field Personnel 3MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences 2
(Date:12/19/2014)... Tampa, FL (PRWEB) December 19, 2014 ... Celliant Revitalizing Bedsheets are now available. Celliant, the ... in both sheets and pillowcases. , There are ... clinically proven additional circulation, increased oxygenation and balanced ... quality, faster healing and pain relief; enhanced athletic ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Silver Dollar ... official world record -- for the first time ever, Silver ... record book, Guinness World Records 2015, listing the park’s wood ... Roller Coaster. In additional awards announced this week, Silver Dollar ... Christmas Lights in the US,” USA Today’s 10Best awards for ...
(Date:12/19/2014)... Eufaula, Oklahoma, located just 9 miles ... state’s largest lake with more than 600 miles of ... a little more than 3,000 residents, hosted its annual ... 6th of December. , Featuring Santa, Christmas lights and ... on Main Street. Narconon Arrowhead’s parade float participated ...
(Date:12/19/2014)... (PRWEB) December 20, 2014 An evening dress ... in a lady’s closet. Discount-Dress.com, a distinguished dresses retailer, has ... buy beautiful dresses in this great shopping platform. Customers ... to the staff's hard work, Discount-Dress.com has been accepted and ... a faster and easier shopping stage for clients. In order ...
(Date:12/19/2014)... 20, 2014 The print component of ... Business subscription of the Toronto Star, with a circulation ... 622,169. The digital component is distributed nationally through a ... top news sites and partner outlets. To explore the ... , The publication features an exclusive interview with ...
Breaking Medicine News(10 mins):Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2
... of existing cancer drugs? A preclinical study presented// at ... Therapeutics, in Prague, Czech Republic concluded that the answer ... treatment options for patients suffering from non-small cell lung ... form in the tissues of the lung. ...
... Toronto, Canada have found that only a small portion of ... the cells as believed earlier. // ,This is the ... found to be the source of the disease. Previously it ... supports the view - stem cells may be responsible for ...
... survey reveals that majority of doctors' fail in recognizing cow's ... in five GPs are not able to correctly diagnose the ... a risk to long-term health. ,The survey of ... Against Allergy and is sponsored by SHS International. The survey ...
... provincial livestock authorities to ensure all poultry farms are sanitized, ... left an indelible loss to the poultry industry. ... at the Department of Livestock Development confirmed that this move ... central provinces. Thailand has been free from bird flu for ...
... increasing numbers of childhood cancer patients survive into adulthood, ... in treatment, say senior cancer and fertility scientists. ... New Zealand are diagnosed with cancer every year, says ... Melbourne’s Royal Children’s Hospital. ,“About 75 ...
... meet diagnostic criteria for PTSD though males experience more ... a review of 25 years of research published by ... of psychological bulletin. ,The authors reviewed 290 ... is more at risk for potentially traumatic events (PTE) ...
Cached Medicine News:Health News:Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs 2Health News:Cancer Stem Cells Alone spread Cancer 2Health News:Majority Of Doctors Tend To Ignore Milk Allergy Cases In Babies 2Health News:Preserving Fertility for Child Cancer Patients 2Health News:Women Are More At Risk For PTSD Than Men 2Health News:Women Are More At Risk For PTSD Than Men 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: